| 发明名称 |
Compositions, Dosage Forms, and Co-Administration of an Opioid Agonist Compound and an Analgesic Compound |
| 摘要 |
The present invention relates generally to the co-administration of an opioid agonist compound and an analgesic compound. In addition, the invention relates to, among other things, dosage forms for co-administration of an opioid agonist compound and an analgesic compound, methods for administering an opioid agonist compound and an analgesic compound, compositions comprising an opioid agonist compound and an analgesic compound, dosage forms comprising an opioid agonist compound and an analgesic compound, and so on. |
| 申请公布号 |
US2014336214(A1) |
申请公布日期 |
2014.11.13 |
| 申请号 |
US201214356486 |
申请日期 |
2012.11.06 |
| 申请人 |
Nektar Therapeutics |
发明人 |
Riley Timothy A.;Pfeiffer Juergen W.;Gursahani Hema |
| 分类号 |
A61K31/485;A61K31/196;A61K31/4468 |
主分类号 |
A61K31/485 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A composition comprising an opioid agonist compound and at least one analgesic compound, wherein the opioid agonist compound is chosen from the formula
OPIOID-X—(CH2CH2O)n—Yand pharmaceutically acceptable salts thereof, wherein OPIOID is a residue of an opioid agonist, X is a physiologically stable linker, n is an integer from 1 to 10, and Y is selected from hydrogen, an end capping group, and a protecting group. |
| 地址 |
San Francisco CA US |
